Screener
Solid Biosciences Inc. SLDB Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Solid Biosciences Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Solid Biosciences Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337935
FAQ
- What is Solid Biosciences Inc.'s debt-to-equity?
- Solid Biosciences Inc. (SLDB) reported debt-to-equity of 0.1× in Q2 2026.
- How has Solid Biosciences Inc.'s debt-to-equity changed year-over-year?
- Solid Biosciences Inc.'s debt-to-equity decreased by 39.6% year-over-year, from 0.1× to 0.1×.
- What is the long-term trend for Solid Biosciences Inc.'s debt-to-equity?
- Over 5 years (2020 to 2025), Solid Biosciences Inc.'s debt-to-equity has grown at a 23.7% compound annual growth rate (CAGR), from 0× to 0.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Solid Biosciences Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude